Symposium
Chairs: Matthew Evison (Manchester, GB), Gilbert Massard (Strasbourg, FR)

Stage I NSCLC: the extent of surgical resection needed, or, better yet, radiotherapy? Paul E. Van Schil (Edegem (Antwerp), Belgium)
Stage IIIA/B NSCLC: rationale for multimodal diversity Wilfried Ernst Erich Eberhardt (Essen, Germany)
Relapsed NSCLC and SCLC: benefits and limitations of systemic treatments beyond the second line Torsten Gerriet Blum (Berlin, Germany)